baber/WOPTO huggingface dataset:
Patent IE-890224-L (IE)
Title: Circuit arrangement for telephone terminal stations
IPC: H04M19/08
Filed: 1989-01-24
Abstract: Telephone terminal stations are connected via network terminating unit to an integrated services digital communications network. When there is power supply failure in the terminating unit, a circuit controls supply to the terminal station from the exchange so that, in the passive state, the power consumption of the telephone terminal station is reduced to a minimum. To this purpose, the voltage for internal users of the telephone terminal station is switched off and only switched on again in the active state, i.e. with transmitting or receiving occupation or operation. <IMAGE>
[DE3803710A1]
Patent IE-860229-L (IE)
Title: Monoclonal antibody
IPC: C07K16/00
Filed: 1986-01-28
Abstract: A monoclonal antibody reactive with a peptide containing the amino acid sequence Lysine-Leucine-Valine-Valine-Valine-Glycine-Alanine-Valine-Glycine-Val ine-Glycin e-Lycine may be used in the diagnosis of primary and metastatic carcinomas. The antibody may be produced by culturing a suitable hybridoma.
Patent IE-900272-L (IE)
Title: Fungicides
IPC: A01N31/08
Filed: 1990-01-24
Abstract: Compounds having the formula (I): <CHEM> in which any two of K, L and M are nitrogen and the other is CE; X and Y are independently hydrogen, halogen, C1-4 alkyl, C3-6 cycloalkyl, C2-4 alkenyl, C2-4 alkynyl, C2-4 alkynyloxy, phenyl, benzyloxy, cyano, isocyano, isothiocyanato, nitro, NR<1>R<2>, NR<1>OR<2>,N3, NHCOR<1>, NR<1>CO2R<2>, NHCONR<1>R<2>, N=CHNR<1>R<2>, NHSO2R<1>, OR<1>, OCOR<1>, OSO2R<1>, SR<1>, SOR<1>, SO2R<1>, SO2OR<1>, SO2NR<1>R<2>, COR<1>, CR<1>=NOR<2>, CHR<1>CO2R<2>, CO2R<1>, CONR<1>R<2>, CSNR<1>R<2>, CN3O2C.C:CH.OCH3, 1-(imidazol-1-yl)vinyl, a 5-membered heterocyclic ring containing one, two or three nitrogen heteroatoms, or a 5- or 6-membered heterocyclic ring containing one or two oxygen or sulphur hetero-atoms, optionally a nitrogen heteroatom and optionally one or two oxo or thioxo substituents; or X and Y, when ortho to one another, join to form a 5-or 6-membered aliphatic or aromatic ring optionally containing one or two oxygen, sulphur or nitrogen atoms or one, two or three nitrogen atoms; A, B, D, E, G, U and V are independently hydrogen, halogen, C1-4 alkyl C1-4 alkoxy, cyano, nitro or trifluoromethyl; and R<1> and R<2> are independently hydrogen, C1-4 alkyl, C2-4 alkenyl or phenyl; the aliphatic moieties of any of theforegoing being optionally substituted with one or more of halogen, cyano, OR<1>, SR<1>, NR<1>R<2>, SiR<1>3 or OCOR<1> and the phenyl moieties of any of the foregoing being optionally substituted with one or more of halogen, C1-4 alkyl, C1-4 alkoxy, nitro or cyano. The compounds are useful as fungicides.
[EP0382375A2]
Patent IE-32197-L (IE)
Title: Pharmceutical composition
IPC: A61K31/545
Filed: 1968-07-15
Abstract: 1,240,546. Medicines containing antibiotics and sulphonamides. RESEARCH CORP. 16 July, 1968 [17 July, 1967], No. 49459/70. Divided out of 1,240,545. Heading A5B. A pharmaceutical composition comprises a heavy metal salt of an antibiotic in admixture with a heavy metal salt of a sulphonamide and/or silver salicylate. The heavy metal salts may be those of gold, nickel, tin, zinc, mercury, platinum, osmium, molybdenum, titanium, copper or silver (preferred). Specified are silver salts of penicillin, cephalothin, colistimethate, and tetracycline; and silver salts of sulphamerazine, sulphonanilide, sulphathiazole, sulphapyridine, sulphamylon, sulphoxazole, sulphapyrimidine, sulphaquinoxaline, substituted benzene sulphonamide and sulphamyl benzothiadiazine dioxide. The compositions may be in the form of a powder, an aqueous suspension, ointment, aerosol or may be incorporated in a film-forming material. Aqueous solutions containing chloride ions e.g. NaCl may be used as carriers for the active ingredients. Specification 1,240,545 is referred to. The compositions are useful in the treatment of burns.
Patent IE-35705-L (IE)
Title: Urea production process
IPC: C07C273/04
Filed: 1971-07-26
Abstract: 1359715 Urea production SNAM PROGETTI SpA 22 July 1971 [3 Sept 1970] 34539/71 Heading C2C A process for the production of urea comprises the steps of reacting CO 2 in a first or carbamate reactor with concentrated aqueous ammonia to form an aqueous solution of ammonium carbamate which is fed to a second or urea reactor wherein the ammonium carbamate so formed is dehydrated to form urea and from which there is obtained an aqueous solution containing urea and unreacted carbamate, and gas consisting of inert gases which are not reactants in the process, and in which process unreacted carbamate present in the urea-containing solution from the second reactor is decomposed and at least part of the decomposition products so formed are recycled in the gaseous phase to said second reactor to condense therein so that the thermal balance of the heat of formation of the carbamate which is decomposed and the latent heats of condensation and dissolution of the carbamate decomposition products is sufficient to supply the heat needed to maintain the contents of the second reactor at the dehydration temperature of the carbamate, and recovering urea from said solution.
[GB1359715A]
Patent IE-36538-L (IE)
Title: Aminophenanthridine derivatives
IPC: C07D221/12
Filed: 1972-07-06
Abstract: 1341809 Phenanthridine derivatives RHONEPOULENC SA 6 July 1972 [8 July 1971] 31773/72 Heading C2C Novel compounds of Formula I (wherein the symbol A represents a straight- or branched-chain alkylene radical containing 1 to 5 carbon atoms, and the symbols R 1 and R 2 each represent the same or a different alkyl radical containing 1 to 5 carbon atoms, or the symbols R 1 and R 2 together with the nitrogen atom to which they are attached represent a 5- or 6- membered mononuclear heterocyclic group, optionally containing a second hetero atom selected from nitrogen, oxygen and sulphur atoms) and acid addition and quaternary ammonium salts thereof are prepared by reacting a compound of formula wherein R 3 is alkyl containing 1 to 3 carbon atoms or an acid addition salt thereof with an amine of H 2 N-A-NR 1 .R 2 . Intermediate of Formula III above, where R 3 is methyl, is prepared by methylating the mercaptan (III R 3 = H) obtained by cyclization of the compound prepared by reacting o-phenylanaline with thiophosgene and sodium hydroxide. Pharmaceutical compositions in conventional forms for oral, rectal, parenteral and topical administration and having anti-arrhythmic activity comprise an above novel compound or salt thereof and a carrier or diluent. (From GB1341809 A) [FR2144609A1]
Patent FI-814113-L (FI)
Inventor: TAYLOR JAMES LONG
IPC: A61K9/50
Filed: 1981-12-21
Abstract: A process for producing lipid membrane structures (vesicles or liposomes) is disclosed, wherein a solution of bilayer forming compounds in a narrowly-defined two component solvent system is dispersed in an aqueous solution and, subsequently, at least a portion of that solvent system is stripped off. This process permits the readily-reproducible production of lipid membrane structures under gentle processing conditions, ideal for use when they contain pharmaceutically-active materials.
Patent FI-843652-L (FI)
Inventor: DE KONING ADRIANUS JOHANNES
IPC: C08G73/12
Filed: 1984-09-18
Abstract: The invention relates to compositions containing 80-30 weight % of bismaleimide-compounds, 5-60 weight % maleimide-amide compounds and 1-10 weight % maleic anhydride derivative.The invention further relates to the preparation of such compositions and to homogeneous curable compositions comprising bismaleimide/maleimide-amide/maleic anhydride compositions according to the invention. The obtained copolymers show good chemical resistance and a high HDT (heat distorsion temperature).
Patent IE-33493-L (IE)
Title: Sulphanilamides
IPC: C07D239/69
Filed: 1969-07-18
Abstract: 1,247,993. Substituted sulphanilamides. F. HOFFMANN-LA ROCHE & CO. A.G. 22 July, 1969 [22 July, 1968], No. 36684/69. Heading C2C. Novel substituted sulphanilamides of the general formula wherein R and R<SP>1</SP> are C 1-18 alkylene groups, R<SP>2</SP> is a hydrogen atom or a C 1-7 alkyl group, m and n are 0 or 1, provided that at least one of m and n is 1, and A is a radical of one of the following formulµ wherein R<SP>4</SP> is a C 1-7 alkyl or C 1-7 alkoxy group or a halogen atom and p is 0, 1 or 2, and, where n is 0, salts thereof with pharmaceutically acceptable bases are prepared by acylation of a sulphanilamide of the general formula wherein B<SP>1</SP> is a hydrogen atom or a blocking group which can be hydrogenolysed or hydrolysed, or a salt thereof with one or more alkoxyalkanoic acids of the general formula and/or or reactive derivatives thereof and, when B<SP>1</SP> is a blocking group, removal of said blocking group by hydrogenolysis or hydrolysis, followed optionally by salification of the product. Substituted sulphanilamides of the general formula wherein r is 0 or 1 and B is a blocking group of the formula R<SP>3</SP>OCO- in which R<SP>3</SP> is a tertiary butyl group or a C 6-12 aryl-C 1-7 alkyl group, produced as intermediates in the above process when r is 1, are also novel. When r is 0, they are produced by acylation of the corresponding sulphanilamide of the fifth general formula above wherein B is a hydrogen atom. Pharmaceutical compositions having antibacterial activity comprise, as active ingredient, a substituted sulphanilamide of the first general formula above or, when n is 0, a salt thereof with a pharmaceutically acceptable base, in association with a compatible carrier and may be administered enterally or parenterally.
[GB1247993A]
Patent IE-33243-L (IE)
Title: Preparation of iron oxide pigment base
IPC: C11D3/00
Filed: 1969-07-24
Abstract: 1280034 Low foam detergent compositions WEST LABORATORIES Inc 25 July 1969 [25 July 1968] 37466/69 Heading C5D A low foam detergent composition comprises (A) a non-ionic surfactant having a molecular weight of from 1800 to 6000 and containing units of ethylene oxide and propylene oxide, the molecular weight of the P.O. units being at least 800 and the E.O. units constituting not more than 65% by wt. of the compound, (B) from 5 to 100% by wt. of component (A) of a non-ionic surfactant containing 2 to 25 moles of ethylene oxide per mole of surfactant and having a molecular weight of at least 300 when E.O. is the only alkylene oxide from which it is derived and of at least 1800 when it is derived from both E.O. and propylene oxide, (C) from 1 to 50% by wt. of component (A) of an aliphatic monocarboxylic acid and/or aliphatic alcohol, the aliphatic radical(s) having 8 to 18 carbon atoms and, when component (C) is an aliphatic monocarboxylic acid, (D) from 1 to 20 times by wt. of component (A) of a mineral acid. Surfactant (B) may be ethoxylated nonyl phenol or alcohol containing 2 to 4 moles of E.O. per mole of surfactant. Component (C) may be capric acid, decyl alcohol or tridecyl alcohol. Optional ingredients are (E) water-soluble solvents e.g. ethanol, ethylene glycol or the butyl ether of ethylene glycol, (F) iodine, (G) hydroxy organic acids e.g. citric acid, (H) alkali metal or alkaline earth metal hydroxides, alkali metal silicates, phosphates or carbonates.
[GB1280034A]
Patent IE-821243-L (IE)
Title: Quinoline derivatives
IPC: C07D491/04
Filed: 1982-05-25
Abstract: Compounds of the formula: <IMAGE> wherein A stands for the radical -(CH2)2- which may bear one or two defined substituents; R1 stands for a (3-4C) alkyl or cyclopropyl radical, or a phenyl radical which may optionally bear one or two defined substituents, or a heteroaryl radical of five or six ring atoms which may optionally bear a (1-3C)alkyl substituent; R2 and R3 stand for hydrogen or a (1-2C)alkyl radical, or R2 stands for a (2-4C)alkylene radical which is linked to one of the carbon atoms forming the two-carbon-atom-backbone of A so as to form, together with the adjacent nitrogen atom, a pyrrolidinyl or piperidyl radical; and one of R4 and R5 stands for hydrogen, and the other stands for hydrogen, a halogen atom or a (1-3C)alkyl or (1-3C)alkoxy radical; and acid-addition salts thereof. Processes for the manufacture of said compounds. Pharmaceutical compositions comprising one of said compounds and a pharmaceutical diluent or carrier. The compounds are 5-hydroxytryptamine antagonists.
[US4435405A]
Patent IE-32501-L (IE)
Title: Data transmission system
IPC: G08C15/06
Filed: 1968-11-21
Abstract: The main features of the present invention reside in the fact that one or more remote groups of subordinated terminal units are serially interconnected and arranged in a closed loop which is terminated at the output and input of a master unit. Each of said groups and said master unit is connected to the transmission line via a modulator and a demodulator. In order to selectively connect a pulse equipment associated with each subordinated terminal unit, and adapted for transmission of data, with the transmission line, each of said subordinated terminal units includes a switching unit, which either connects or disconnects the associated pulse equipment from the transmission line. According to the invention, the novelty resides both in the arrangement of the network connecting the subordinated terminal units with the master pulse equipment, and the procedure for the exchange of information between the master pulse equipment and the subordinated terminal unit, and vice versa, through the closed loop, and by selectively actuating said switching unit.
[US4293948A]
Patent IE-38696-L (IE)
Title: Tape tab applicator
IPC: B26D5/00
Filed: 1973-09-12
Abstract: A tape tab cutting and applying mechanism in which a rotating orbiting tape head picks up a tape tab at one station and transports it to an applying station for applying tape tabs at spaced intervals on a moving web or line of successive objects. The tape tab is essentially perpendicular to the path of the tape head at the pick-up station and parallel to the web or article at the applying station.
[US3960646A]
Patent IE-35924-L (IE)
Title: Hose clamp
IPC: F16L33/04
Filed: 1971-12-23
Abstract: 1317240 Clamps L C WEYDERT 15 Dec 1971 [16 Feb 1971] 58222/71 Heading E2B A clamp, for a hose having a helical reinforcing wire embedded in it, comprises a pair of helical wires 15, 20 which are contracted by end lugs 2, 3 welded to the wires and drawn together by a screw 9, the ends 16, 18, 22 of the wires bridging the gap between the lugs. In the modification shown in Fig. 5, the clamping wires are partly replaced by flexible cables 55, 56.
[GB1317240A]
Patent IE-851935-L (IE)
Title: Herbicidal bipyridinium salt composition and alginic acid
IPC: A01N25/14
Filed: 1985-08-06
Abstract: Bipyridinium quaternary salt compositions are prepared which are dry, free-flowing, wettable powders. The solid compositions are complexes of the bipyridinium salts and algin.
[US4832730A]
Patent IE-812063-L (IE)
Title: Grading the band gaps of amorphous alloys and devices
IPC: C23C16/455
Filed: 1981-09-07
Abstract: A graded bandgap material comprises amorphous Si containing F(a- Si : F) together with a varying amount of a bandgap modifier (e.g. Ge, Sn, C or N). H, may also be incorporated in the material which may be doped. The graded bandgap material may be used in Schottky, MIS and PIN solar cells or in photoconductive or electrophotographic devices.
[GB2083701A]
Patent IE-902114-L (IE)
Title: Dibenzo£1,5|dioxocin-5-one derivatives, their use in¹medicaments and processes for their preparation
IPC: A61P9/04
Filed: 1990-06-12
Abstract: The present invention relates to 7H-dibenzo[1,5]-dioxocin-5-ones of the general formula (I) 
<IMAGE>
 in which R<1> - R<8>, R<14> and R<15> have the meaning given in the description, to their use in medicaments, and processes for their preparation, in particular their use in medicaments having a circulatory activity.
Patent IE-782502-L (IE)
Title: Cephalosporins
IPC: A61P31/04
Filed: 1978-12-19
Abstract: Cephalosporin compounds of the formula <IMAGE> wherein R and R2 are hydrogen or protecting groups, R1 is hydrogen or methoxy, R3 is hydrogen or C1-C4 alkyl and R4 is C1-C4 alkyl, are broad spectrum antibiotics or intermediates thereto.
[US4200745A]
Patent IE-802744-L (IE)
Title: Platinum (iv)-diamine complexes
IPC: A61P35/00
Filed: 1980-12-03
Abstract: Platinum(IV)-diamine-complexes, a process for the preparation thereof, a process for the preparation of a medicine using such a platinum(IV)-diamine-complex for the treatment of malignant tumors in mice as well as the shaped medicine thus obtained. This invention relates to novel platinum-diamine complexes, a pharmaceutical composition using the novel complexes and methods of treating malignant tumors in mice using the pharmaceutical composition.
[US4431666A]
Patent IE-873047-L (IE)
Title: Production of optically active bicyclo £3.3.0| octane¹derivatives
IPC: C12P41/00
Filed: 1987-11-12
Abstract: PCT No. PCT/DE87/00518 Sec. 371 Date Jul. 13, 1988 Sec. 102(e) Date Jul. 13, 1988 PCT Filed Nov. 12, 1987 PCT Pub. No. WO88/03569 PCT Pub. Date May 19, 1988.Claimed is a process for the production of optically active bicyclo[3.3.0]octanedione-carboxylic acid esters of Formula I   <IMAGE> (I)  wherein R1 and R2 jointly represent an oxygen atom, or R1 and R2 individually represent the residue OR4 where R4 means methyl- or ethyl-, and R3 is a straight or branched-chain alkyl group of 1-3 carbon atoms, comprising enantioselectively saponifying and decarboxylating with  alpha -chymotrypsin an optically inactive, prochiral bicyclo[3.3.0]octanedionedicarboxylic acid diester of Formula II <IMAGE> (II)  wherein R1, R2 and R3 have the meanings set forth above, and recovering a compound of Formula I.
Patent IE-893690-L (IE)
Title: Treatment of obesity
IPC: A61K31/135
Filed: 1989-11-17
Abstract: N,N-dimethyl-1-1[1-(4-chlorophenyl)cyclobutyl]-3-methylbutylamine hydrochloride is used in the treatment of obesity in humans.
[WO9006110A1]
Patent NO-832232-L (NO)
Inventor: JEFFREY GAINES CLAYTON
IPC: B01D53/34
Filed: 1983-06-20
Abstract: Fluid streams containing hydrogen sulfide from a steam turbine or from a sour gas stream are contacted with an aqueous solution of a polyvalent metal chelate and an oxidizing agent whereby the hydrogen sulfide is concerted to free sulfur and then to soluble sulfur compounds. The metal chelate is reduced to a lower oxidation state metal chelate and reduced metal chelate is subsequently oxidized with air back to the higher oxidation state and reused.
Patent NO-834526-L (NO)
Inventor: BRENHOLDT IRVING R
IPC: G01N33/34
Filed: 1983-12-08
Abstract: In an apparatus and method for determining the percentage of solid particles in a suspension (consistency), diffused radiant energy is directed from a source (14) toward a suspension (11) to be measured. The portion of the energy which is forward-scattered by the suspension is detected (18) and a first signal indicative of the magnitude of the forward-scattered energy is produced. The portion of energy which is back-scattered by the suspension is detected (16) and a second signal indicative of the magnitude of back-scattered energy is produced. The first and second signals are combined (30) at a predetermined ratio to produce a feedback signal used to control the intensity of energy emitted from the radiant energy source (14). The intensity of energy emitted from the source (14) is a function of the forward-scattered and back-scattered energy and is directly proportional to the consistency of the suspension (11) being measured. By monitoring the power driving the radiant energy source, a display calibrated in terms of percent consistency can be provided.
Patent NO-875108-L (NO)
Inventor: STEM STEPHEN CHARLES
IPC: C07C9/16
Filed: 1987-12-08
Abstract: This invention relates to a process for the production of an isomerate (e.g. a gasoline blending component) wherein after isomerization, a separatory sieve (preferably ferrierite) selectively adsorbs unreacted normal paraffins and mono-methyl-branched paraffins but not di-methyl-branched paraffins.
Patent NO-883574-L (NO)
Inventor: PRYCKER M L F DE
IPC: H04L12/933
Filed: 1988-08-11
Abstract: Packet switching network with first (DN) and second (RN) cascaded parts including first and second switching modules respectively. In the second switching modules the path selection is controlled by routing information contained in the packets. In the first switching modules this selection is performed without using routing information only for a path set up packet, whilst for the following packets use is made of routing information on the route followed by the path set up packet. Each module decides to multiplex an input stream on an output only when a calculated traffic load is smaller than a limit value. This load is calculated from traffic load parameters contained in the path set up packet.
Patent NO-884976-L (NO)
Inventor: WARREN BETH ZARTMAN
IPC: A23B7/154
Filed: 1988-11-08
Abstract: Compositions and process are disclosed for treating freshly cut surfaces of edible plant parts by dipping the fresly cut parts in an aqueous solution containing edible ingredients which simultaneously protects the plant parts from degradation and coloration by oxidative, enzymatic, microbial and metal ion effects.
Patent NO-901761-L (NO)
Inventor: NIELSEN OVE
IPC: B25G1/08
Filed: 1990-04-20
Abstract: PCT No. PCT/DK87/00134 Sec. 371 Date Jun. 22, 1990 Sec. 102(e) Date Jun. 22, 1990 PCT Filed Oct. 23, 1987 PCT Pub. No. WO89/03734 PCT Pub. Date May 5, 1989.A tool ring (1) for securing blanks in a machine of the type comprising a pair of rotating rings whose opposite, plane side faces are formed with a plurality of holding tools (8, 11) so adapted that an oblong blank (16) can be secured substantially radially between a pair of holding tools in respective ones of said rings. At least one ring has a groove (4) which is adapted to receive holding tools and spacer tools (9, 10, 10', 12) of which at least the holding tools have a convex face (23, 33) to engage the engagement face (19) of said groove. The holding tools (8, 9, 11) are mutually spaced by the spacer tools, and some of the spacer tools (10, 12) are positioned in the groove, while the position of the spacer tools is defined by the cooperation between edge faces (24, 25, 30, 31) on the tools.
Patent NO-902403-L (NO)
Inventor: LUNDQUIST ESKIL SIGFRID
IPC: B29C67/04
Filed: 1990-05-30
Abstract: A decorative web, sheet or panel of plastic or some other material is made by applying a liquid to a support in a predetermined pattern. Then a decorative material is applied, preferably in the form of a powder, whereupon such decorative material has not been bonded with the liquid, is removed. The application of liquid in a new pattern and decorative material of a colour or structure deviating from that of the decorative material first applied, as well as the removal of excess material are repeated, until the desired final pattern is obtained, whereupon the liquid is evaporated or caused to be sorbed by the decorative material, and the obtained aggregate is molten or sintered, where appropriate after levelling and application of a further layer.
Patent NO-910347-L (NO)
Inventor: MENTINK LEON
IPC: A23C15/14
Filed: 1991-01-29
Abstract: Process for refining mixtures resulting from treatments of fatty substances with cyclodextrin and containing complexes of cyclodextrin with fatty acid type lipophilic compounds, characterised in that the said mixtures are subjected to a thermal treatment at a temperature above 100 DEG C in the presence of a solvent system comprising water, in that the different fractions or raffinates resulting from the thermal treatment are separated out and in that these raffinates are recovered.
Patent NO-912462-L (NO)
Inventor: SOHDA TAKASHI
IPC: C07F9/568
Filed: 1991-06-24
Abstract: A bisphosphonic acid derivative of the general formula (I): <CHEM> wherein A is an optionally substituted cyclic group; R<1> is hydrogen atom or a lower alkanoyl group; R<2>, R<3>, R<4> and R<5> are the same or different and are hydrogen atom or a lower alkyl group; m is 0, 1 or 2; and n is an integer from 2 to 10, or a salt thereof is disclosed. A process for its production and a bone resorption inhibitor containing the compound of the general formula (I) or a salt thereof are also disclosed.